Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, will be participating in the upcoming Life Sciences Investor Forum, scheduled for June 24, 2021. During the presentation, Cybin’s CEO Doug Drysdale…
TAAT(TM) (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP2) today provided a summary of several notable accomplishments it has achieved since first listing on the Canadian Securities Exchange (“CSE”) one year ago. The company’s many milestones include…
Pressure BioSciences (OTCQB: PBIO) has announced its CEO will be participating in the upcoming Emerging Growth Conference. PBIO is a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables, and services…
CNS Pharmaceuticals’ (NASDAQ: CNSP) lead drug candidate, Berubicin, is a novel anthracycline, the first of which to appear capable of crossing the blood-brain barrier based on limited clinical data. The company is currently developing Berubicin…
XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience technology accelerator, recently announced its drug formulation and development, conducted primarily by its wholly owned German subsidiary, Vektor Pharma TF GmbH, are on schedule and…
According to CEO Evan Gappelberg, Nextech is the only diversified small-cap company participating in the rapidly growing digital transformation The company is ideally positioned to capitalize on the rapid market adoption environment accompanying the ongoing…
Splash Beverage Group (OTCQB: SBEV), a portfolio company of leading beverage brands, today announced enhancing its commitment to developing market share for sustainably focused, innovative and socially conscious brands. According to the update, reports published…
WTER 2020 FY revenues make company largest alkaline water company in the U.S. In addition, the brand is one of the top-10 largest enhanced water brands in the country Research shows that Alkaline88 has the…
Collaboration will use TumorGenesis’ expertise in cancer cell culture growth media in combination with Cellevate’s specialty in emerging field of nanofiber matrixes. Cutting-edge technology can help avoid mistakes in $2.6 billion process of bringing new…
PlantX Life’s (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) CEO Julia Frank recently appeared on Optimal Self Conversations, an inspirational forum hosted by Jeremy Herider, a three-sport professional athlete and productivity coach. The podcast features interviews…
Nextech AR Solutions (OTCQB: NEXCF) (NEO: NTAR) (CSE: NTAR) (FSE: N29), a diversified leading provider of augmented reality (“AR”) experience technologies and services, announced that it has completed the acquisition of Threedy.ai Inc. The acquisition…
Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, announced that it has completed its 51st preclinical study; the study is a critical step in the company’s progress in the Investigational…
Knightscope Inc. has seen a 46% drop in reported crime at one location and has operated over 1,000,000 hours of service for its autonomous security robots nationwide The versatility of the robots have seen their…
Brain cancer drug developer CNS Pharmaceuticals is actively enrolling patients for a potentially pivotal Phase 2 trial of the company’s lead drug candidate, Berubicin, a promising candidate for treating a devastating condition CNS’s focus has…
The agricultural produce treatment space has been active in recent years, attracting more than $26 billion in new investment in 2020 In May 2021, Save Foods Inc. closed on a $12 million public offering and…
The company has developed and brought to market a pediatric NeuroCap EEG testing in pediatrics may help diagnose autism, one of the fastest-growing developmental disorders in the US, and provide better treatment for pediatric patients…
Brain Scientific (OTCQB: BRSF), a commercial-stage medical device and software company, has created powerful yet affordable solutions that bring brain diagnostics to settings where it was previously impossible or difficult to conduct neurological testing. Concussions…
Cybin (NEO: CYBN) (OTCQB: CLXPF) has announced that its CEO Doug Drysdale will be participating at the 2021 Emerging Growth Conference, which is scheduled for June 23, 2021.As part of his participation, Drysdale will be…
Company expects reporting on interim analysis for the first 18 patients of a Phase 2 multicenter clinical trial of Berubicin in adult GBM patients during the first half of 2022 One patient from the first…
AI solutions company Infobird has announced an agreement to provide e-commerce platform upgrades for elderly consumer footwear manufacturing giant Zu Li Jian The Beijing-based company delivers intelligent B2B services, and the Zu Li Jian agreement…